KLRC2 and HIV infectious disease: As previously described in HIV infection,16, 17, 18 primary HIV-infected patients from the Optiprim-ANRS 147 study showed high frequencies of NKG2C+ NK cells, irrespectively of their PHI stage, stable over the first 3 months of cART, but highly variable among the patients.